Nomura Asset Management CO LTD Ionis Pharmaceuticals Inc Transaction History

Nomura Asset Management CO LTD

  • $28.9 Billion
  • Q2 2024
Number of Shares
0
Previous 0 NaN%
Holding current value
$0
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024
BUY
$36.45 - $47.7 $0 - $0
0 New
0 $0
Q1 2024

May 13, 2024
BUY
$42.03 - $53.55 $0 - $0
0 New
0 $0
Q4 2023

Feb 09, 2024
BUY
$43.39 - $51.63 $0 - $0
0 New
0 $0
Q3 2023

Nov 03, 2023
BUY
$38.5 - $47.13 $0 - $0
0 New
0 $0
Q2 2023

Aug 14, 2023
BUY
$34.73 - $43.33 $0 - $0
0 New
0 $0
Q4 2021

Feb 01, 2022
SELL
$25.61 - $35.1 $0 - $0
0 Closed
0 $0
Q3 2021

Nov 12, 2021
SELL
$33.54 - $40.55 $248,766 - $300,759
-7,417 Closed
0 $0
Q2 2021

Aug 06, 2021
SELL
$34.54 - $47.25 $548,598 - $750,471
-15,883 Reduced 68.17%
7,417 $296,000
Q1 2021

May 14, 2021
BUY
$42.51 - $63.78 $21,255 - $31,890
500 Added 2.19%
23,300 $1.05 Million
Q4 2020

Feb 12, 2021
BUY
$45.3 - $60.27 $9,060 - $12,054
200 Added 0.88%
22,800 $1.29 Million
Q1 2020

May 14, 2020
BUY
$41.6 - $63.4 $108,160 - $164,840
2,600 Added 13.0%
22,600 $1.07 Million
Q2 2019

Aug 13, 2019
BUY
$62.09 - $86.14 $1.24 Million - $1.72 Million
20,000 New
20,000 $1.29 Million
Q1 2019

May 10, 2019
BUY
$52.92 - $81.17 $0 - $0
0 New
0 $0
Q1 2019

May 10, 2019
BUY
$52.92 - $81.17 $0 - $0
0 New
0 $0
Q4 2018

Feb 12, 2019
BUY
$43.37 - $59.54 $0 - $0
0 New
0 $0
Q1 2018

May 14, 2018
SELL
$44.08 - $55.05 $0 - $0
0 Closed
0 $0
Q4 2017

Feb 14, 2018
BUY
$50.3 - $64.39 $0 - $0
0 New
0 $0
Q3 2017

Nov 13, 2017
BUY
$45.56 - $59.57 $0 - $0
0
0 $0

Others Institutions Holding IONS

# of Institutions
389
Shares Held
125M
Call Options Held
2.25M
Put Options Held
510K
View Full List

About IONIS PHARMACEUTICALS INC

IONS Quotes by TradingView
  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $5.64B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Nomura Asset Management CO LTD Portfolio

Follow Nomura Asset Management CO LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nomura Asset Management CO LTD, based on Form 13F filings with the SEC.

News

Stay updated on Nomura Asset Management CO LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email